vs
BridgeBio Pharma, Inc.（BBIO）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
BridgeBio Pharma, Inc.的季度营收约是REPUBLIC BANCORP INC的1.6倍（$154.2M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs -126.2%，领先150.4%），BridgeBio Pharma, Inc.同比增速更快（2521.2% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-56.5M）
本文提供的介绍实际对应 Brent Saunders 的个人履历，而非BridgeBio Pharma, Inc. 的企业信息。Brent Saunders是美国生物制药行业高管与企业家，目前担任博士伦公司董事长兼首席执行官，曾主导参与多起大型医药并购交易，同时涉足特殊目的收购公司领域，在医疗板块拥有丰富行业经验。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
BBIO vs RBCAA — 直观对比
营收规模更大
BBIO
是对方的1.6倍
$94.3M
营收增速更快
BBIO
高出2515.9%
5.3%
净利率更高
RBCAA
高出150.4%
-126.2%
自由现金流更多
RBCAA
多$217.6M
$-56.5M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $154.2M | $94.3M |
| 净利润 | $-194.6M | $22.8M |
| 毛利率 | 94.7% | — |
| 营业利润率 | -90.5% | 29.3% |
| 净利率 | -126.2% | 24.2% |
| 营收同比 | 2521.2% | 5.3% |
| 净利润同比 | 27.2% | 20.0% |
| 每股收益（稀释后） | $-1.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBIORBCAA
| Q4 25 | $154.2M | $94.3M | ||
| Q3 25 | $120.7M | $93.5M | ||
| Q2 25 | $110.6M | $93.8M | ||
| Q1 25 | $116.6M | $135.8M | ||
| Q4 24 | — | $89.5M | ||
| Q3 24 | — | $88.1M | ||
| Q2 24 | — | $86.9M | ||
| Q1 24 | $211.1M | $120.3M |
净利润BBIORBCAA
| Q4 25 | $-194.6M | $22.8M | ||
| Q3 25 | $-184.9M | $29.7M | ||
| Q2 25 | $-183.8M | $31.5M | ||
| Q1 25 | $-169.6M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $26.5M | ||
| Q2 24 | — | $25.2M | ||
| Q1 24 | $-36.2M | $30.6M |
毛利率BBIORBCAA
| Q4 25 | 94.7% | — | ||
| Q3 25 | 94.6% | — | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 97.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 99.7% | — |
营业利润率BBIORBCAA
| Q4 25 | -90.5% | 29.3% | ||
| Q3 25 | -120.3% | 40.4% | ||
| Q2 25 | -121.4% | 43.0% | ||
| Q1 25 | -89.5% | 44.1% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | — | 38.4% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | 0.2% | 32.2% |
净利率BBIORBCAA
| Q4 25 | -126.2% | 24.2% | ||
| Q3 25 | -153.2% | 31.8% | ||
| Q2 25 | -166.2% | 33.5% | ||
| Q1 25 | -145.4% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | — | 30.1% | ||
| Q2 24 | — | 29.0% | ||
| Q1 24 | -17.1% | 25.4% |
每股收益（稀释后）BBIORBCAA
| Q4 25 | $-1.00 | — | ||
| Q3 25 | $-0.95 | — | ||
| Q2 25 | $-0.95 | — | ||
| Q1 25 | $-0.88 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-0.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $570.1M | $220.0M |
| 总债务越低越好 | $2.0B | — |
| 股东权益账面价值 | $-2.1B | $1.1B |
| 总资产 | $936.0M | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BBIORBCAA
| Q4 25 | $570.1M | $220.0M | ||
| Q3 25 | $643.0M | $484.2M | ||
| Q2 25 | $756.9M | $484.8M | ||
| Q1 25 | $540.6M | $793.0M | ||
| Q4 24 | — | $432.2M | ||
| Q3 24 | — | $530.9M | ||
| Q2 24 | — | $400.1M | ||
| Q1 24 | $519.7M | $546.4M |
总债务BBIORBCAA
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BBIORBCAA
| Q4 25 | $-2.1B | $1.1B | ||
| Q3 25 | $-1.9B | $1.1B | ||
| Q2 25 | $-1.8B | $1.1B | ||
| Q1 25 | $-1.6B | $1.0B | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | — | $979.7M | ||
| Q2 24 | — | $955.4M | ||
| Q1 24 | $-1.0B | $935.6M |
总资产BBIORBCAA
| Q4 25 | $936.0M | $7.0B | ||
| Q3 25 | $998.3M | $7.0B | ||
| Q2 25 | $1.1B | $7.0B | ||
| Q1 25 | $881.6M | $7.1B | ||
| Q4 24 | — | $6.8B | ||
| Q3 24 | — | $6.7B | ||
| Q2 24 | — | $6.6B | ||
| Q1 24 | $849.3M | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-56.4M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-56.5M | $161.1M |
| 自由现金流率自由现金流/营收 | -36.6% | 170.9% |
| 资本支出强度资本支出/营收 | 0.0% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流BBIORBCAA
| Q4 25 | $-56.4M | $168.2M | ||
| Q3 25 | $-109.6M | $33.3M | ||
| Q2 25 | $-80.7M | $8.4M | ||
| Q1 25 | $-199.2M | $93.2M | ||
| Q4 24 | — | $149.0M | ||
| Q3 24 | — | $51.3M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | $-219.5M | $71.2M |
自由现金流BBIORBCAA
| Q4 25 | $-56.5M | $161.1M | ||
| Q3 25 | $-110.0M | $30.8M | ||
| Q2 25 | $-81.3M | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | $-220.2M | $69.1M |
自由现金流率BBIORBCAA
| Q4 25 | -36.6% | 170.9% | ||
| Q3 25 | -91.2% | 32.9% | ||
| Q2 25 | -73.5% | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | -104.3% | 57.5% |
资本支出强度BBIORBCAA
| Q4 25 | 0.0% | 7.5% | ||
| Q3 25 | 0.4% | 2.6% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | 0.3% | 1.7% |
现金转化率BBIORBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
